From: Effects of hypoxia on human cancer cell line chemosensitivity
 | A2780 | ACHN | H69 | MCF-7 | U-937 | |||||
---|---|---|---|---|---|---|---|---|---|---|
 | Anoxia | Hypoxia | Anoxia | Hypoxia | Anoxia | Hypoxia | Anoxia | Hypoxia | Anoxia | Hypoxia |
5-FU | 0.29*** | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.7** | 1.5 |
Acriflavine | 0.56 | N/A | 2.4* | 1.0 | 0.19** | 0.23** | N/A | 0.52 | 0.99 | 0.81* |
Bortezomib | 0.10*** | 0.20*** | >4.0** | >6.0** | 0.14** | 0.76 | N/A | N/A | 1.1 | 0.85 |
Cisplatin | 1.6 | 0.90 | 3.6** | 1.1 | 0.22** | 0.21** | 0.37*** | 0.49** | 0.52*** | 0.43*** |
Digitoxin | 3.6 | 0.94 | N/A | >133** | <0.050 | <0.56 | N/A | N/A | 2.0 | 0.95 |
Digoxin | 2.4 | 1.1 | N/A | >80** | N/A | <0.24 | N/A | N/A | 1.2 | 0.85 |
Docetaxel | 2.3 | 1.0 | 44*** | 7.3** | 1.0 | 1.8 | 0.75 | 0.58 | N/A | N/A |
Doxorubicin | 1.3 | 0.50 | 3.5** | 1.1 | 1.1 | <0.46 | >2.1* | 0.59* | 0.69* | 0.61** |
Etoposide | 1.3 | 0.73 | >3.7** | >6.5** | 0.46* | 0.75 | N/A | N/A | 0.87 | 0.80* |
Gemcitabine | N/A | 0.62 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Irinotecan | 1.3 | 1.3 | 5.3*** | >2.7** | 0.32 | N/A | >2.7 | N/A | 1.1 | 0.86 |
Melphalan | 2.0 | 2.6 | 4.9*** | 5.1** | 0.24** | N/A | 0.89 | N/A | 0.61** | 0.55** |
Mitomycin C | 0.17*** | 0.22 | 1.1 | 2.0** | 0.11*** | 0.18** | 0.63* | 0.31*** | 0.45*** | 0.44*** |
Rapamycin | 1.2 | 0.34 | 1.2 | 1.3 | 0.14** | 0.08** | N/A | N/A | 0.34* | 1.8 |
Sorafenib | 0.85 | 0.87 | 1.6* | 1.2 | 0.58 | 1.8 | 1.5 | 1.4 | 2.0 | 1.2 |
Thalidomide | N/A | N/A | N/A | N/A | <0.89* | N/A | <0.28 | N/A | 0.21*** | <0.44* |
Tirapazamine | 0.044*** | 0.045*** | 0.1*** | 0.10*** | 0.025*** | 0.042*** | 0.055*** | 0.062*** | 0.072*** | 0.094*** |
Topotecan | 0.023*** | 0.50 | N/A | 1.5 | N/A | 0.31** | N/A | N/A | 2.2* | 0.72 |
Vincristine | 5.0** | 0.010 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | >1 |